A paired comparison between human skin and hairless guinea pig skin in vitro permeability and lag time measurements for 6 industrial chemicals

Cutaneous and Ocular Toxicology

Volumn 28, Issue 3, 2009, Pages 107-113

  Frasch, H Frederick ^a   Barbero, Ana M ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

1,2 dichloroethane; Aniline; Benzene; Diethyl phthalate; Lag time; Naphthalene; Permeability; Skin absorption; Tetrachloroethylene

Indexed keywords

1,2 DICHLOROETHANE; ANILINE; BENZENE; NAPHTHALENE; PHTHALIC ACID DIETHYL ESTER; TETRACHLOROETHYLENE;

ADULT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; LIPOPHILICITY; MALE; NONHUMAN; SKIN ABSORPTION; SKIN PERMEABILITY;

ADULT; ANIMALS; CHROMATOGRAPHY, GAS; DIFFUSION CHAMBERS, CULTURE; FEMALE; GUINEA PIGS; HAZARDOUS SUBSTANCES; HUMANS; INDUSTRY; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; RISK ASSESSMENT; SKIN; SKIN ABSORPTION; TIME FACTORS; TOXICITY TESTS; YOUNG ADULT;

CAVIA;

EID: 70350623102     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520902950474     Document Type: Article

References (22)

1. Bronaugh RL, Stewart, RF, Congdon ER. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982; 62:481-488.
2. Bronaugh R. Determination of percutaneous absorption by in vitro techniques. In: Bronaugh R, Maibach H, eds. Percutaneous Absorption: Mechanism, Methodology, and Drug Delivery; New York: Marcel Dekker Inc. 1985:267-279.
3. Sato K, Sugibayashi K, Morimoto Y. Species differences in percutaneous absorption of nicorandil. J Pharm Sci 1991; 80:104-107.
4. Panchagnula R, Stemmer K, Ritschel WA. Animal models for transdermal drug delivery. Methods Find Exp Clin Pharmacol 1997; 19:335-341.
5. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in invitro percutaneous absorption. Int J Pharm 2001; 215:51-56.
6. Vecchia BE, Bunge A. Animal models: A comparison of permeability coefficients for excised skin from humans and animals. In: Riviere JE, ed. Dermal Absorption Models in Toxicology and Pharmacology; Boca Raton, FL: CRC Press. 2006:305-333.
7. Vallet V, Cruz C, Licausi J, Bazire A, Lallement G, Boudry I. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin: Validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations. Toxicology 2008; 246:73-82.
8. Behl CR, Kumar S, Malick AW, Patel H, Char H, Piemontese D. Choice of membranes for in vitro skin uptake studies and general experimental technics. In: Kemppainen BW, Reifenrath WG, eds. Methods for Skin Absorption; Boca Raton, FL: CRC. 1990:1-21.
9. Sueki H, Kudoh K, Kligman AM. Hairless guinea pig skin: Anatomical basis for studies of cutaneous biology. Eur J Dermatol 2000; 10:357-364.
10. Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicol In Vitro 2009; 23:1-13.
11. Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. In vitro/in vivo correlation studies for transdermal delta 8-THC development. J Pharm Sci 2004; 93:1154-1164. (Pubitemid 38529689)
12. Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: In vitro/in vivo correlation. Pharm Res 2004; 21:1137-1145.
13. Paudel KS, Nalluri BN, Hammell DC, Valiveti S, Kiptoo P, Hamad MO, Crooks PA, Stinchcomb AL. Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo. J Pharm Sci 2005; 94:1965-1975.
14. Banks SL, Pinninti RR, Gill HS, Crooks PA, Prausnitz MR, Stinchcomb AL. Flux across of [sic] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res 2008; 25:1677-1685.
15. Frasch HF, Barbero AM. Application of solid-phase microextraction to in vitro skin permeation experiments: Example using diethyl phthalate. Toxicol In Vitro 2005; 19:253-259.
16. Frasch HF, Barbero AM. The transient dermal exposure: Theory and experimental examples using skin and silicone membranes. J Pharm Sci 2008; 97:1578-1592.
17. Moody RP, Nadeau B, Chu I. In vivo and in vitro dermal absorption of benzo[a]pyrene in rat, guinea pig, human and tissue- cultured skin. J Dermatol Sci 1995; 9:48-58.
18. Storm JE, Collier SW, Stewart RF, Bronaugh RL. Metabolism of xenobiotics during percutaneous penetration: Role of absorption rate and cutaneous enzyme activity. Fundam Appl Toxicol 1990; 15:32-141.
19. Hood HL, Wickett RR, Bronaugh RL. In vitro percutaneous absorption of the fragrance ingredient musk xylol. Food Chem Toxicol 1996; 34:483-488.
20. Moody RP, Nadeau B. An automated in vitro dermal absorption procedure. 3. In vivo and in vitro comparison with the insect repellent n,n-diethyl-m- toluamide in mouse, rat, guinea-pig, pig, human and tissue-cultured skin. Toxicol In Vitro 1993; 7:167-176.
21. Moody RP, Nadeau B. In vitro dermal absorption of N,N-diethylm- toluamide (DEET) in rat, guinea pig, and human skin. Toxicol In Vitro 1995; 8:263-275.
22. Anderson KE, Maibach HI, Anjo MD. The guinea-pig: An animal model for human skin absorption of hydrocortisone, testosterone and benzoic acid? Br J Dermatol 1980; 102:447-453.